CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-04-24 | Tyree James L Director | Grant or award | +13,950 | 35,620 | ||
| 2015-03-02 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +92,674 | $1,673,692.44 | $155.1B | 31,673,853 |
| 2015-02-20 | Aguiar Michael W President & CEO | Shares withheld for taxes | −6,789 | $18.22 | $124K | 458,107 |
| 2015-02-20 | Aguiar Michael W President & CEO | Shares withheld for taxes | −6,789 | $18.22 | $124K | 446,148 |
| 2015-01-07 | WITEK THEODORE L JR Sr. VP, Corp Partnerships | Grant or award | +71,429 | 71,429 | ||
| 2015-01-07 | WITEK THEODORE L JR Sr. VP, Corp Partnerships | Grant or award | +71,429 | 71,429 | ||
| 2015-01-07 | ABERCROMBIE GEORGE B Sr. VP, Corp. Partnerships | Grant or award | +71,429 | 81,429 | ||
| 2015-01-07 | Aguiar Michael W President & CEO | Grant or award | +176,056 | 464,896 | ||
| 2015-01-07 | dEsparbes Eric SVP and CFO | Grant or award | +36,972 | 139,443 | ||
| 2014-12-22 | Tyree James L Director | Grant or award | +6,500 | 21,670 | ||
| 2014-12-22 | PEPE PAUL Director | Grant or award | +6,500 | 21,670 | ||
| 2014-12-22 | WALTRIP WILLIAM H Director | Grant or award | +3,250 | 103,314 | ||
| 2014-12-22 | FRIEDMAN CATHY Director | Grant or award | +6,500 | 21,670 | ||
| 2014-11-04 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +832,456 | $12,786,524.16 | $10644.2B | 31,581,179 |
| 2014-10-30 | Kearney Terrence C Director | Grant or award | +23,133 | 23,133 | ||
| 2014-10-16 | dEsparbes Eric SVP and CFO | Grant or award | +102,471 | 102,471 | ||
| 2014-08-20 | LEE JUNNING Sr. VP, Technical Operations | Shares withheld for taxes | −3,261 | $22.76 | $74K | 262,198 |
| 2014-08-20 | Mammen Mathai SVP, Research & Early Clin Dev | Shares withheld for taxes | −3,261 | $22.76 | $74K | 334,040 |
| 2014-08-20 | Shafer Bradford J Sr VP, Gen. Counsel, Secretary | Shares withheld for taxes | −3,261 | $22.76 | $74K | 443,013 |
| 2014-08-20 | BLUM LEONARD M Sr VP, Chief Comm. Officer | Shares withheld for taxes | −3,261 | $22.76 | $74K | 401,538 |
Page 17 of 23 · 446 trades